CC
PFE icon

Cornerstone Capital’s Pfizer PFE Stock Holding History

Cornerstone Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Buy
74,730
+50,415
+207% +$1.34M 0.21% 53
2025
Q4 		$605K Hold
24,315
– – 0.06% 74
2025
Q3 		$620K Buy
24,315
+7,033
+41% +$174K 0.06% 70
2025
Q2 		$419K Sell
17,282
-313
-2% -$7.3K 0.04% 78
2025
Q1 		$446K Hold
17,595
– – 0.05% 79
2024
Q4 		$467K Sell
17,595
-891
-5% -$24.2K 0.05% 85
2024
Q3 		$535K Buy
18,486
+891
+5% +$26K 0.05% 83
2024
Q2 		$492K Buy
+17,595
New +$484K 0.05% 77
2023
Q4 		– Sell
-14,800
Closed -$491K – 93
2023
Q3 		$491K Hold
14,800
– – 0.06% 71
2023
Q2 		$543K Hold
14,800
– – 0.06% 70
2023
Q1 		$604K Hold
14,800
– – 0.07% 66
2022
Q4 		$758K Sell
14,800
-1,780
-11% -$85.3K 0.1% 63
2022
Q3 		$726K Buy
16,580
+1,430
+9% +$69.5K 0.1% 58
2022
Q2 		$794K Sell
15,150
-440
-3% -$22.4K 0.1% 58
2022
Q1 		$807K Buy
15,590
+7,990
+105% +$415K 0.09% 62
2021
Q4 		$449K Buy
7,600
+1,000
+15% +$49.5K 0.05% 70
2021
Q3 		$284K Hold
6,600
– – 0.03% 78
2021
Q2 		$258K Hold
6,600
– – 0.03% 80
2021
Q1 		$239K Hold
6,600
– – 0.03% 78
2020
Q4 		$243K Sell
6,600
-356
-5% -$13.1K 0.03% 78
2020
Q3 		$242K Buy
6,956
+210
+3% +$7.36K 0.03% 74
2020
Q2 		$209K Hold
6,746
– – 0.04% 70
2020
Q1 		$209K Hold
6,746
– – 0.04% 63
2019
Q4 		$251K Hold
6,746
– – 0.04% 76
2019
Q3 		$230K Sell
6,746
-948
-12% -$34.5K 0.04% 70
2019
Q2 		$316K Buy
7,694
+7,620
+10,297% +$303K 0.05% 65
2019
Q1 		$297K Sell
74
-7,304
-99% -$293K 0.05% 65
2018
Q4 		$306K Sell
7,378
-548
-7% -$22.7K 0.05% 68
2018
Q3 		$331K Hold
7,926
– – 0.05% 66
2018
Q2 		$273K Sell
7,926
-234
-3% -$8K 0.05% 66
2018
Q1 		$275K Hold
8,160
– – 0.05% 71
2017
Q4 		$280K Hold
8,160
– – 0.05% 73
2017
Q3 		$276K Buy
8,160
+234
+3% +$7.52K 0.05% 71
2017
Q2 		$253K Hold
7,926
– – 0.05% 70
2017
Q1 		$257K Sell
7,926
-2,951
-27% -$93K 0.05% 71
2016
Q4 		$335K Hold
10,877
– – 0.07% 66
2016
Q3 		$350K Sell
10,877
-633
-5% -$21.2K 0.08% 62
2016
Q2 		$384K Sell
11,510
-3,109
-21% -$99.2K 0.08% 58
2016
Q1 		$411K Sell
14,619
-5,533
-27% -$158K 0.09% 56
2015
Q4 		$617K Sell
20,152
-3,795
-16% -$119K 0.14% 49
2015
Q3 		$714K Sell
23,947
-2,635
-10% -$84.5K 0.18% 50
2015
Q2 		$846K Buy
26,582
+5,903
+29% +$192K 0.19% 50
2015
Q1 		$683K Sell
20,679
-264
-1% -$8.39K 0.18% 45
2014
Q4 		$619K Buy
20,943
+632
+3% +$18.1K 0.16% 47
2014
Q3 		$570K Hold
20,311
– – 0.16% 47
2014
Q2 		$572K Hold
20,311
– – 0.15% 45
2014
Q1 		$619K Hold
20,311
– – 0.18% 43
2013
Q4 		$590K Hold
20,311
– – 0.17% 45
2013
Q3 		$554K Hold
20,311
– – 0.17% 47
2013
Q2 		$540K Buy
+20,311
New +$561K 0.18% 43

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cornerstone Capital's PFE Position: Q1 2026 in Review

Cornerstone Capital increased its Pfizer (PFE) stake by 207% in Q1 2026, buying an estimated $1.34M and bringing the position to 74,730 shares worth $2.1M. The position accounts for 0.21% of the portfolio, ranked #53.

Cornerstone Capital first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cornerstone Capital held 74,730 shares of Pfizer worth $2.1M as of Q1 2026.
  • Cornerstone Capital bought 50,415 Pfizer shares in Q1 2026, an estimated $1.34M.
  • Pfizer made up 0.21% of Cornerstone Capital's portfolio in Q1 2026, its #53 holding.
  • Cornerstone Capital first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cornerstone Capital's 13F filing for Q1 2026, filed 12 May 2026.